- Home
- GILD vs UBS Comparison
GILD vs UBS Comparison
Compare GILD & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- UBS
- Stock Information
- Founded
- GILD 1987
- UBS 1862
- Country
- GILD United States
- UBS Switzerland
- Employees
- GILD N/A
- UBS N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- UBS Major Banks
- Sector
- GILD Health Care
- UBS Finance
- Exchange
- GILD Nasdaq
- UBS Nasdaq
- Market Cap
- GILD 113.0B
- UBS 101.3B
- IPO Year
- GILD 1992
- UBS N/A
- Fundamental
- Price
- GILD $92.98
- UBS $29.99
- Analyst Decision
- GILD Buy
- UBS Buy
- Analyst Count
- GILD 26
- UBS 2
- Target Price
- GILD $96.71
- UBS N/A
- AVG Volume (30 Days)
- GILD 6.4M
- UBS 1.2M
- Earning Date
- GILD 02-11-2025
- UBS 02-04-2025
- Dividend Yield
- GILD 3.38%
- UBS 3.52%
- EPS Growth
- GILD N/A
- UBS N/A
- EPS
- GILD 0.10
- UBS 1.35
- Revenue
- GILD $28,299,000,000.00
- UBS $47,207,000,000.00
- Revenue This Year
- GILD $6.54
- UBS N/A
- Revenue Next Year
- GILD N/A
- UBS N/A
- P/E Ratio
- GILD $937.76
- UBS $21.13
- Revenue Growth
- GILD 3.31
- UBS 28.10
- 52 Week Low
- GILD $62.07
- UBS $26.01
- 52 Week High
- GILD $98.90
- UBS $33.34
- Technical
- Relative Strength Index (RSI)
- GILD 52.30
- UBS 30.54
- Support Level
- GILD $90.27
- UBS $31.66
- Resistance Level
- GILD $93.59
- UBS $32.33
- Average True Range (ATR)
- GILD 2.12
- UBS 0.37
- MACD
- GILD -0.21
- UBS -0.30
- Stochastic Oscillator
- GILD 50.91
- UBS 5.11
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About UBS UBS Group AG Registered
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.